Literature DB >> 31198045

Glycyrrhizin-Assisted Transport of Praziquantel Anthelmintic Drug through the Lipid Membrane: An Experiment and MD Simulation.

Alexandra V Kim1,2, Ekaterina A Shelepova1,2, Olga Yu Selyutina1, Elizaveta S Meteleva3, Alexander V Dushkin3, Nikolai N Medvedev1,2, Nikolay E Polyakov1,3, Nikolay Z Lyakhov3.   

Abstract

Praziquantel (PZQ) is one of the most widespread anthelmintic drugs. However, the frequent insufficient application of PZQ after oral administration is associated with its low solubility, penetration rate, and bioavailability. In the present study, the permeation of PZQ through a 1,2-dioleoyl- sn-glycero-3-phosphocholine (DOPC) membrane was investigated to probe glycyrrhizin-assisted transport. Glycyrrhizin (or glycyrrhizic acid, GA), a natural saponin, shows the ability to enhance the therapeutic activity of various drugs when it is used as a drug delivery system. However, the molecular mechanism of this effect is still under debate. In the present study, the transport rate was measured experimentally by a parallel artificial membrane permeation assay (PAMPA) and molecular dynamics (MD) simulation with DOPC lipid bilayers. The formation of the noncovalent supramolecular complex of PZQ with disodium salt of GA (Na2GA) in an aqueous solution was proved by the NMR relaxation technique. PAMPA experiments show a strong increase in the amount of the penetrating praziquantel molecules in comparison with a saturated aqueous solution of pure drug used as a control. MD simulation of PZQ penetration through the bilayer demonstrates an increase in permeability into the membrane in the presence of a glycyrrhizin molecule. A decrease in the free energy barrier in the middle of the lipid bilayer was obtained, associated with the hydrogen bond between PZQ and GA. Also, GA reduces the local bilayer surface resistance to penetration of PZQ by rearranging the surface lipid headgroups. This study clarifies the mechanism of increasing the drug's bioavailability in the presence of glycyrrhizin.

Entities:  

Keywords:  DOPC; NMR; PAMPA; drug delivery; glycyrrhizic acid; lipid bilayer; membrane penetration; molecular dynamics; praziquantel; solubility enhancement

Mesh:

Substances:

Year:  2019        PMID: 31198045     DOI: 10.1021/acs.molpharmaceut.9b00390

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Effects of Three-time Administration of a Supramolecular Complex of Praziquantel with Disodium Glycyrrhizinate on Trematode Opisthorchis felineus in Hamsters.

Authors:  Damira Avgustinovich; Maria Lvova; Galina Vishnivetskaya; Mikhail Tsyganov; Irina Orlovskaya; Lyudmila Toporkova; Elena Goiman; Aleksander Dushkin; Nikolay Lyakhov; Viatcheslav Mordvinov
Journal:  Acta Parasitol       Date:  2021-01-08       Impact factor: 1.440

2.  Multimodal Investigation into the Interaction of Quinacrine with Microcavity-Supported Lipid Bilayers.

Authors:  Nirod Kumar Sarangi; Amrutha Prabhakaran; Tia E Keyes
Journal:  Langmuir       Date:  2022-05-13       Impact factor: 4.331

3.  pH-Sensitive Glycyrrhizin Based Vesicles for Nifedipine Delivery.

Authors:  Olga Yu Selyutina; Anna V Mastova; Ekaterina A Shelepova; Nikolay E Polyakov
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

4.  Effect of glycyrrhizic acid on phospholipid membranes in media with different pH.

Authors:  O Yu Selyutina; P A Kononova; N E Polyakov
Journal:  Russ Chem Bull       Date:  2022-01-26       Impact factor: 1.704

5.  Mechanism of the enhancing effect of glycyrrhizin on nifedipine penetration through a lipid membrane.

Authors:  A V Kim; E A Shelepova; V I Evseenko; A V Dushkin; N N Medvedev; N E Polyakov
Journal:  J Mol Liq       Date:  2021-10-09       Impact factor: 6.165

6.  New Aspects of the Antioxidant Activity of Glycyrrhizin Revealed by the CIDNP Technique.

Authors:  Aleksandra A Ageeva; Alexander I Kruppa; Ilya M Magin; Simon V Babenko; Tatyana V Leshina; Nikolay E Polyakov
Journal:  Antioxidants (Basel)       Date:  2022-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.